Literature DB >> 6975277

A new procedure for the quantitation of nuclear and cytoplasmic androgen receptors.

A M Traish, R E Muller, H H Wotiz.   

Abstract

Experimental conditions for the measurement of prostatic androgen receptors occupied with unlabeled hormone are described. The assay allows quantitation of cytoplasmic and nuclear receptors occupied with unlabeled ligand by exchange with 17 beta-hydroxy-17 alpha-methyl [3H]estra-4,9,11-trien-3-one at 0 degrees C. The mercurial reagent mersalyl acid (0.2 mM) is used to promote dissociation of more than 90% receptor-bound steroid. The half-time of this reaction is 10-15 min. The reaction is reversible by addition of dithiothreitol or monothioglycerol. Treatment of the receptor with mersalyl and displacement of this reagent by thiol reagents does not alter the steroid binding affinity of the receptor or the sedimentation characteristics. Binding is measured by the hydroxylapatite procedure and all buffers contain 10 mM sodium molybdate. This assay circumvents many of the difficulties associated with conventional exchange assays performed either at elevated temperature or at 16 degrees C for 20-24 h, such as receptor degradation or incomplete exchange.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6975277

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  5 in total

1.  Side gland of Suncus murinus as a new model of sebaceous gland: 5 alpha-reductase, androgen receptor, and nuclear androgen content in male and female animals.

Authors:  S Komada; S Itami; S Kurata; S Takayasu
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

Review 2.  Testosterone Therapy in Men With Prostate Cancer.

Authors:  Alan L Kaplan; Jim C Hu; Abraham Morgentaler; John P Mulhall; Claude C Schulman; Francesco Montorsi
Journal:  Eur Urol       Date:  2015-12-21       Impact factor: 20.096

3.  Effects of tamoxifen on vaginal blood flow and epithelial morphology in the rat.

Authors:  Noel N Kim; Miljan Stankovic; Abdullah Armagan; Tulay T Cushman; Irwin Goldstein; Abdulmaged M Traish
Journal:  BMC Womens Health       Date:  2006-09-13       Impact factor: 2.809

Review 4.  Shifting the Paradigm of Testosterone Replacement Therapy in Prostate Cancer.

Authors:  Michael A Bell; Jeffrey D Campbell; Gregory Joice; Nikolai A Sopko; Arthur L Burnett
Journal:  World J Mens Health       Date:  2018-03-22       Impact factor: 5.400

Review 5.  The effects of testosterone replacement therapy on the prostate: a clinical perspective.

Authors:  Saiful Miah; Tharu Tharakan; Kylie A Gallagher; Taimur T Shah; Mathias Winkler; Channa N Jayasena; Hashim U Ahmed; Suks Minhas
Journal:  F1000Res       Date:  2019-02-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.